Performance

MLYS -58.42%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
MLYS	+3.13%	-56.43%	-58.42%	—	-67.80%	-1.11	0.00%

Summary

MLYS at a glance

MLYS returned -58.42% over the past year. Its worst drop in that year was -67.80%, smaller than 7% of stocks on Redstone, and its Sharpe ratio of -1.11 beats 3% of stocks on Redstone. It pays no dividends.

Ranking

How MLYS ranks

Current Drawdown

-66.60%

Rolling Volatility

91.04%

Actions

Metrics

Risk Indicators

Alpha-87.61%

Beta1.68x

Sharpe-1.11

Sortino-1.56

Omega0.82

Calmar-0.86

Martin-1.74

Profile

About MLYS

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $1.4B
Listed: Feb 2023
Employees: 76
Headquarters: Radnor, PA
Website: mineralystx.com

Comparisons

MLYS: Mineralys Therapeutics, Inc.

MLYS at a glance

How MLYS ranks

Current Drawdown

Rolling Volatility

About MLYS

Related comparisons